Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhNGF in Dry Eye Disease (REDUCO)
NCT06244316Phase 2Completed
- Sponsor
- Dompé
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of cenegermin in dry eye disease (DED), sponsored by Dompé. Started Jan 2024; status: completed.
02
Drugs
cenegermin
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06244316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06244316.